CliffBio
small molecule

DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlmatica Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameDULOXETINE HYDROCHLORIDE
Active ingredientDULOXETINE HYDROCHLORIDE
StrengthEQ 80MG BASE
Dosage formCAPSULE, DELAYED REL PELLETS
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2026
Marketing statusRX

More from Almatica Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DULOXETINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio